Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Outpatient Intravenous Insulin Treatment (Therapy)

This article is for physicians, hospitals, and other providers who bill Medicare contractors (Fiscal Intermediaries (FI), carriers, or Medicare Administrative Contractors (A/B MACs)) for providing outpatient intravenous insulin therapy
(OIVIT) to Medicare beneficiaries.

Download the Guidance Document

Final

Issued by: Centers for Medicare & Medicaid Services (CMS)

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.